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is feasible and effective
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Abdul Rashid Qureshi1, Bengt Lindholm1 and Peter Rutherford6
Abstract
Background: Patients with unplanned dialysis start (UPS) have worse clinical outcomes than non-UPS patients, and
receive peritoneal dialysis (PD) less frequently. In the OPTiONS study of UPS patients, an educational programme (UPS-EP)
aiming at improving care of UPS patients by facilitating care pathways and enabling informed choice of dialysis modality
was implemented. We here report on impact of UPS-EP on modality choice and clinical outcomes in UPS patients.
Methods: This non-interventional, prospective, multi-center, observational study included 270 UPS patients from 26
centers in 6 European countries (Austria, Germany, Denmark, France, United Kingdom and Sweden) who prior to
inclusion presented acutely, or were being followed by nephrologists but required urgent dialysis commencement by an
acutely placed CVC or PD catheter. Effects of UPS-EP on choice and final decision of dialysis therapy and outcomes within
12 months of follow up were analysed.
Results: Among 270 UPS patients who had an unplanned start to dialysis, 214 were able to receive and 203 complete
UPS-EP while 56 patients - who were older (p = 0.01) and had higher Charlson comorbidity index (CCI; p < 0.01) - did not
receive UPS-EP. Among 177 patients who chose dialysis modality after UPS-EP, 103 (58%) chose PD (but only 86% of
them received PD) and 74 (42%) chose HD (95% received HD). Logistic regression analysis showed that diabetes 1.88 (1.
05 – 3.37) and receiving UPS-EP, OR = 4.74 (CI, 2.05 – 10.98) predicted receipt of PD. Patients choosing PD had higher CCI
(p = 0.01), higher prevalence of congestive heart failure (p < 0.01) and myocardial infarction (p = 0.02), and were more
likely in-patients (p = 0.02) or referred from primary care (p = 0.02). One year survival did not differ significantly between
PD and HD patients. Peritonitis and bacteraemia rates were better than international guideline standards.
Conclusions: UPS-EP predicted patient use of PD but 14% of those choosing PD after UPS-EP still did not receive the
modality they preferred. Patient survival in patients choosing and/or receiving PD was similar to HD despite age and
comorbidity disadvantages of the PD groups.
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Background
Dialysis initiation through planned fashion with perman-
ent access and a careful organised preparation for the
chosen dialysis modality after education is viewed as the
most beneficial for patients’ clinical outcomes. However,
there is still a significant number of patients that due to
unforeseeable deterioration of renal function, delayed
presentation to healthcare professionals or other clinical
and non-clinical factors, start dialysis in an unplanned
manner [1]. This is still a common and important problem
in dialysis centres globally and 24-49% of patients are re-
ported to commence dialysis in such a way [1]. According
to United States Renal Data System (USRDS) data, around
60% of patients who progressed to end-stage renal disease
(ESRD) did not have a distinct plan for treatment at the
time of start dialysis therapy [2]. Unplanned patients will
tend to obtain in-centre HD as a default dialysis option
[3], reflected in high usage (up to 80%) of central venous
catheter (CVC) [2]. In Europe there is a challenging trend
of decreasing use of arteriovenous fistula, AVF (42% in
2005 and 32% in 2009), while CVC use increased from
58% to 68% [4].
The definition of unplanned start (UPS) varies which
can make comparisons difficult but in most studies un-
planned dialysis start is defined using, in part, first dialysis
access with no functional AV fistula or permanent PD
catheter. Recently the term “suboptimal” dialysis was
proposed to define dialysis commenced as a hospital in-
patient, and/or with CVC (without permanent access) [5].
Other criteria for defining UPS have also been proposed:
(1)Late referral defined as time between referral to the
nephrology unit and first dialysis ranging between 1
and 6 months [6]. Late referral is not entirely
synonymous with UPS; however, early referral tends
to be a predictor of better coordination of medical
care in pre-dialysis stage, management of CKD
complications, and education around dialysis option
that is based on informed consent, and may therefore
decrease probability of UPS. A recent meta-analysis
shows that early referral is associated with reduced
mortality and hospitalization, greater uptake of PD
and timely placement of permanent dialysis access [7].
This is clinically important as patients who start
dialysis with CVCs have increased chances of
prolonged CVC use and associated complications [8].
(2)Biochemical parameters e.g. estimated glomerular
filtration rate (eGFR) - defined as early (above a
certain level of eGFR) or late (below that level of
eGFR) start which can be misleading as it does
not reflect a clinical pathway. The randomized,
multicentre, controlled IDEAL study aimed to
evaluate the optimal dialysis start based on
estimated GFR (eGFR) [9] of early vs late initiation.
There was no difference in terms of survival
between these eGFR defined groups but more
patients in the “late” start category had UPS with
temporary access.
(3)Speed of the need for dialysis - emergent dialysis,
urgent dialysis and non-urgent dialysis as defined
by Ghaffari [3]: Emergent start < 48 hours, urgent
start > 48 hours and up to 2 weeks, whilst
non-urgent start were those that were able to
plan and start with their modality of choice [3].
(4)Being known or “unknown” to nephrology care.
There are “known” patients that despite nephrology
follow up, have UPS due to unpredictable GFR
decline or care pathway failures. In addition, there is
a cohort of truly “unknown” patients that present
with undiagnosed CKD stage 5.
Despite discrepancies in this clinical nomenclature which
makes comparisons challenging, it is clear that UPS
patients have more clinical problems such as increased
morbidity and mortality [10], increased use of healthcare
resources (e.g. hospital days) [11] and are less likely to
receive a choice of dialysis modality and choose a home
dialysis therapy, and typically start on in-centre HD, com-
pared with patients starting planned dialysis [12]. This is
partly access driven as patients starting with a CVC have
higher mortality risk as compared with those using PD or
start HD with AVF or arteriovenous grafts [13] and have
increased risk of septicaemia [14]. Studies evaluating
whether it is possible to educate UPS patients and com-
mence or switch early to PD therapy are relatively infre-
quent; however, single centre studies show that UPS
patients can commence PD [3, 15–18] and PD in UPS pa-
tients can give outcomes similar to unplanned HD [19, 20].
However, clinical concerns remain over UPS and
whether it is even feasible to educate UPS patients who
generally have started on dialysis around different modal-
ities and whether the system of care in dialysis units can
be organized to educate and deliver choice of dialysis
modality. Therefore this study was designed to examine
the feasibility and impact of an educational programme
intended to affect the UPS patient pathway (UPS-EP) and
deliver a tailored educational programme to allow modal-
ity choice.
Methods
Study design
This was a non-interventional, prospective, multi-centre,
observational study of unplanned start (UPS) patients, who
all received dialysis therapy, with up to 12 months follow
up time. Participating centres had implemented the UPS-
EP into their routine clinical practice. The development
and implementation of the UPS-EP has been described
elsewhere [21] but briefly consists of;
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(1)Analysis of UPS patient flow in a dialysis unit with
process improvement approach to understand and
resolve issues - the units mapped out their
unplanned start pathway to understand and improve
specific bottlenecks and constraints. The aim was to
improve the pathway to patient education, decision
making and formation of permanent access
(AV fistula or catheter).
(2)A specific patient education program focusing on
the dialysis modality choice facing UPS patients,
who had started on dialysis in an unplanned fashion,
supported by decision support tools. This was
developed in collaboration with 5 dialysis units in
Europe and academic institutions specialized in
patient education and aims at facilitate the decision
making process for dialysis modality choice. There is
no global consensus regarding the structure and
content for modality education although standards
have been suggested for planned start CKD
education programs [22]. Programs tend to focus
on general CKD knowledge, treatment as well as
dialysis modality decisions [23]. In contrast, the
UPS-EP educational focus is on the modality
decision itself since this is the critical element of
education to improve health literacy at UPS. This
approach is followed in other conditions eg oncology
[24, 25] since at diagnosis, patients need treatment
option information, and to understand the impact of
the disease and the treatment options on themselves.
Thus, the UPS-EP included information on HD,
PD, home HD and conservative care as well as
transplantation and was delivered to the patients
during at least 3 individual sessions by nurses using
motivational interviewing methodology, at the pace
determined by the nurse assessing the clinical
condition. Educational material included a dialysis
options booklet matching the educational material
delivered by the nurse, a photograph based book
showing HD, PD and home HD and a unit-specific
modality video alongside HD unit visit and
demonstration of PD. In addition, the decision
support tools within the UPS-EP contained three
aids, chosen by the educators for individual
patients from the Ottawa online decision aid,
a self-completion balance scale, and a set of decision
cards which allowed the patient to prioritize the
value to them of specific issues and factors which
related to CKD treatment.
Twenty-six centres in 6 European countries (Austria,
Denmark, Germany, France, Sweden and United Kingdom)
aimed to recruit all UPS patients presenting in their units.
In these centres, all UPS patients were identified on clinical
presentation and considered actively for education within
the structured UPS-EP with the use of decision support
tools. UPS patients who were judged clinically to not be
suitable for this educational approach or would not be able
to make a modality choice for medical reasons were still
identified and included in the overall UPS cohort. Patients
could receive the UPS-EP at the time of presentation or
following dialysis start.
Inclusion and exclusion criteria
As discussed in the introduction the literature around
patient definition is confusing but this study aimed to
focus on patients based on the nature of the dialysis start
rather than simply on the referral timing or the speed of
first dialysis start following access placement. UPS patients
were considered eligible for the study on the basis of the
following inclusion criteria;
(1)they had CKD stage 5,
(2)were aged between 18 and 90 years old at the time
when informed consent was signed, and
(3)had commenced dialysis in an unplanned way on
the basis of clinical criteria of presentation to the
nephrologist within 1 month of needing dialysis
(as ‘unknown” patient) AND/OR being followed
by nephrologist but requiring urgent dialysis
commencement by CVC or an acutely placed
PD catheter.
The exclusion criteria included a diagnosis of acute kid-
ney injury (AKI) rather than CKD stage 5 - given in NICE
Guideline [26] - a clinical decision to actively follow a con-
servative clinical management plan (chronic dialysis is not
to be performed) and other serious or acute conditions
that, in the investigator’s opinion, would preclude partici-
pation in the study or where life expectancy was estimated
at 6 months or less.
Patients gave informed consent for inclusion and data
collection at the time of UPS presentation or in the
recovery phase around the time of hospital discharge. The
scheme of the study recruitment and follow up is presented
as Additional file 1: Figure S1 in additional file.
Data collection
Demographic or clinical data were collected either from the
patients’ healthcare records or from routine patient-health
care professional interactions at baseline, 6 months and 12
months. This included patient demographics, medical his-
tory including comorbidities assessed by Charlson comor-
bidity index (CCI), dialysis access procedures, details of the
presentation with end-stage renal failure requiring UPS and
details of starting modality, access interventions and the
number and length of hospitalization linked to UPS. Data
collection at 6 months (defined as 6 months following first
HD session or first PD day at home if PD from the start of
Machowska et al. BMC Nephrology  (2017) 18:18 Page 3 of 12
dialysis) and 12 months (defined as 12 months following
first HD session or first PD day at home if PD from the
start of dialysis) recorded patient status, dialysis modality,
and if, when changed, details of dialysis access procedures,
brief details of dialysis related infectious events and number
and length of any hospitalizations.
Impact of UPS-EP and patients flow
The primary objective of the study was to evaluate the
impact and effectiveness of the UPS-EP on the choice of
dialysis therapy (HD or PD) made by UPS patients who
had been initiated on dialysis in an unplanned fashion. In
addition, the patient flow through the educational pro-
gram to ultimate decision making was analysed by logistic
regression to identify predictors of receiving PD vs HD
dialysis therapy at any time point during the study, includ-
ing PD as an initial UPS dialysis modality. The dependent
categorical variable was PD or HD. Explanatory variables
included in the model were: age, gender, eGFR at first
dialysis session, presence of diabetes, hospitalization for
UPS, time between first referral to nephrologist and first
dialysis session and received education. The flow of
patients into and through UPS-EP in terms of eligibility
and feasibility of education, completion of education
program and decision making was collected.
Peritonitis and bacteraemia rate
Peritonitis rate was calculated according to ISPD guidelines
[27] and expressed as months of PD at risk, divided by
number of episodes, and expressed as interval in months
between episodes and also as number of infections for a
time period, divided by dialysis-years’ time at risk, and
expressed as episodes per year.
In order to compare the severity of the infection events
we applied the same calculation scheme to show the
bacteraemia rate among HD patients calculated based on
the number of haemodialysis bloodstream infection. In our
study, the definitions are classified according to the
KDIGO Vascular Access guidelines [28]. Bloodstream in-
fection was defined as blood culture results positive for the
presence of bacteria with or without the accompanying
symptom or fever.
During the study, one patient undergoing HD had a
peritonitis event, this patient was initially managed with
HD, chose PD but peritonitis occurred during the surgical
procedure of PD catheter placement, and PD was never
performed. For the purpose of this analysis of peritonitis
rate during PD therapy in UPS patients, this peritonitis
event was not taken into account.
Statistical methods
Data are expressed as median (10th to 90th percentile) or
percentage or odds ratio (95% CI, confidence intervals), as
appropriate. Statistical significance was set at the level of
p < 0.05. For comparison between two groups non –para-
metric Wilcoxon test was used - and for three or more
groups - non-parametric Kruskal-Wallis ANOVA test was
used. Chi-square test was used for nominal variables.
Logistic regression was performed to see the predictors of
receiving PD vs HD dialysis therapy during the study,
including initial dialysis modality. Explanatory variables in
the model include age, gender, eGFR, presence of diabetes,
hospitalization for unplanned start, time between first
referral to nephrologists and first dialysis session and
received education. Kaplan Meier survival analysis was
performed to investigate one-year survival. We did not
take under consideration multiple comparisons; therefore
the presented data have a descriptive nature. Statistical
analyses were performed using statistical software SAS
version 9.4 (SAS Campus Drive, Cary, NC, USA).
Results
Baseline characteristics of UPS patients
Two hundred and seventy UPS patients who had an un-
planned dialysis start were recruited in the OPTiONS
Registry, 230 were followed up for 6 months and 197
patients completed 12 months follow-up. Seventy three
patients were prematurely withdrawn from the study
due to death (n = 47), renal transplantation (n = 10), lost
to follow-up (n = 7) or other reason (n = 8), whereas only
one patient voluntary withdraw from the study. Fourteen
patients died during the first 90 days after commencing
dialysis. The diagram showing the flow of 270 UPS
patients enrolled in the study is presented in additional
file as Additional file 1: Figure S2
The baseline characteristics of UPS patients are pre-
sented in Table 1. Their median age was 69 years, and
64% were males. At inclusion, comorbidities included
diabetes (41%), congestive heart failure (31%), myocardial
infarction (18%) and peripheral vascular disease (18%),
and the median value of CCI was 6. Patients were referred
to the nephrology unit equally often from primary care
and from other hospital specialties, and the majority were
referred during an in-patient admission. The majority of
patients were hospitalized for the UPS (91%). The median
eGFR level at the time of first dialysis initiation was 7 ml/
min/1.73 m2. Only 17% of patients initiated dialysis on the
referral day, 32% patients received their first dialysis after
the first day but within 2 weeks, 15% had their first dialysis
2 weeks to 3 months, and 36% after more than 3 months
after presenting.
The majority of UPS patients were able to receive UPS-
EP (n = 214) whereas 56 patients never received education
(Fig. 1). Some (n = 104) patients were reported by the
clinical teams as not being suitable as a PD candidate and
reasons other than patient choice (22%) were as follows:
obesity (2%), hernia (1%), previous surgical scarring/
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adhesions (6%), domestic circumstances (4%), cognitive
barriers (5%) and physical barriers (6%).
Patients who never received UPS-EP were significantly
older (p = 0.01), more comorbid (CCI, p < 0.01), and they
were distributed differently across the countries (Table 1).
There was a trend regarding patient source with a higher
in-patient admission in the group who never received
UPS- EP (p = 0.09).
Effect of UPS-EP
The majority, 214 out of 270 patients who had an un-
planned dialysis start, were suitable for making decision
on preferred dialysis modality after receiving and com-
pleting UPS-EP (Fig. 1). Most of the 177 patients (177/
214) received UPS-EP immediately or shortly after UPS
presentation, 34 patients within the first 6 months after
commencing dialysis, and 3 patients after 12 months.
Whereas 203 out of the 214 UPS-EP patients completed
the educational programme, 11 patients did not complete
because of their medical condition (n = 8) or unwillingness
to participate (n = 3). Following the completion of UPS-
EP, 177 patients made a decision on initial dialysis modal-
ity, 103 patients chose PD and 74 HD, while 26 patients
did not make, or were unable for clinical reasons to make
a decision on a preferred dialysis therapy, following com-
pletion of UPS-EP.
Logistic regression analysis of factors influencing the
dialysis modality received among the 270 UPS patients
enrolled in the study showed that having diabetes: OR =
1.88 (CI, 1.05 – 3.37) and receiving UPS-EP: OR = 4.74
(CI, 2.05 – 10.98) were statistically significant predictors
of receiving PD (Table 2). Including CCI as a variable in
the model had no additive value and was not a signifi-
cant predictor of receiving PD (data not shown).
Table 1 Baseline characteristics of all 270 UPS patients, 214 patients who received UPS-EP and 56 patients who did not receive UPS-EP
UPS patients n = 270 Received UPS-EP
n = 214
Not received UPS-EP
n = 56
P value
Age 69 (40-83) 67 (37-84) 72 (54 – 83) 0.01
Sex, M/F, % 64/36 64/36 64/36 1.00
eGFR, ml/min /1.73 m2 BSA 7 [4–16] 7 [4–16] 7 [4–16] 0.53
Charlson comorbidity index, CCI 6 [2–10] 6 [2–10] 7 [5–10] <0.01
Comorbidities, %
Diabetes
Congestive heart failure
Myocardial infarct
Peripheral vascular disease
41
31
18
18
39
28
17
16
50
41
21
25
0.17
0.07
0.56
0.12
Primary renal diseasea, %
Chronic renal failure, etiology unknown
Glomerulonephritis
Renal vascular disease
Diabetic nephropathy
Otherb
13
20
20
25
22
12
22
18
23
25
14
14
16
32
24
0.59
Patients source, %
In-patient admission
Out-patient referral
71
29
68
32
80
20
0.09
Referral, %
Primary care
Other hospital specialty
Missing/unknown
51
48
1
53
46
1
48
52
0
0.64
Hospitalization for the
unplanned start, %
91 90 93 0.80
Countries, %
United Kingdom
Germany
Denmark
Sweden
Austria
France
24
36
18
4
11
7
29
34
17
5
7
8
5
43
20
2
28
2
<0.001
Values are expressed as median (10-90 percentiles) or percentage. CCI, Charlson comorbidity index; eGFR, estimated glomerular filtration rate, significant values
are marked in bold (p < 0.05)
aCause of renal disease
bPyelonephritis, interstitial nephropathy, cystic kidney disease, inherited renal disease, renal hypoplasia, multisystem renal disease, myeloma, amyloid, other
renal disease
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Characteristics of patients completing UPS-EP and making
modality choice
We looked for underlying demographic differences in the
characteristics of UPS patients who completed UPS-EP
and declared a choice of PD or HD since differences could
then influence clinical outcomes observed over follow up.
Table 3 shows the clinical characteristics of the 177 pa-
tients who completed the UPS educational program and
chose a preferred dialysis modality, PD (n = 103) or HD
(n = 74). These two groups could be considered as analo-
gous to the “intention to treat” populations in studies
comparing two different therapies - the PD group and HD
group are defined by their preferred choice of modality,
not actual modality. Patients who chose PD were more co-
morbid (CCI, p = 0.01), with higher prevalence of congest-
ive heart failure (p < 0.01), were distributed differently
across countries (p < 0.01) and with the trend towards
higher number of in-patient admissions (p = 0.05) than in
the HD choosing group. These results demonstrate that
PD was not being selected only by younger and fitter
patients and that a wide range of patients were receiving
education and choosing PD. There were 7 patients whose
first modality was HD who all completed USP-EP decided
to remain on HD and not switch to PD but expressed a
choice of transfer to Home HD. It is unclear how many
were trained and transferred during the study but all
remained on HD so are included within the HD group.
Characteristics of patients who did or did not receive
their preferred dialysis modality
Among the investigated UPS patients not all received the
modality that they chose after education and supported
decision making. We compared PD and HD patients who
at any point of the study received their chosen dialysis
modality (Additional file 1: Table S1). In our study, 89
patients chose and received PD and 70 patients chose and
received HD according to their recorded decision. PD
patients were significantly more comorbid (CCI, p = 0.02),
Fig. 1 Flow of 270 UPS patients through UPS-EP
Table 2 Logistic regression analysis evaluating predictors of receiving PD therapy in 270 UPS patients
Pseudo r = 0.09 Odds ratio (95% CI) P value
Age, ≥ 69 years 1.26 (0.71 – 2.24) 0.42
Gender, male versus female 1.51 (0.82 - 2.78) 0.19
eGFR, ≤7 ml/min/1.73 m2 1.33 (0.75 – 2.35) 0.33
Diabetes, presence versus absence 1.88 (1.05 – 3.37) 0.03
Hospitalization, yes/no 0.51 (0.21 – 1.30) 0.16
Time between first referral to nephrologists and first dialysis, ≥ 15 days 0.84 (0.48 – 1.48) 0.55
UPS-EP, received versus not received 4.74 (2.05 – 10.98) <0.001
CCI Charlson comorbidity index, eGFR estimated glomerular filtration rate, significant values are marked in bold (p < 0.05)
Median age: 69 years; median eGFR: 7 ml/min/1.73 m2; median time between first referral to nephrologists and first dialysis: 15 days;
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had more often medical history of congestive heart failure
(p < 0.001) and myocardial infarction (p = 0.02), were
significantly more often from in-patient UPS admission
(p = 0.02) or referred form primary care (p = 0.04), and
were differently distributed among participating countries
(p < 0.001).
In addition, we characterized patients who throughout
the study never received their expressed will of choice of
dialysis modality: 14 patients chose and never received
PD, and 4 patients chose but never received HD. On
comparing those groups with the groups that received
their chosen modalities to investigate putative difference
in patient characteristics there were no significant differ-
ences between those groups (Additional file 1: Table S1).
In particular patients who chose and received PD were
not different clinically from those who chose but did not
receive PD.
Characteristics of patients who actually received PD and HD
Since not all the patients received their preferred therapy
we compared patients who completed the UPS-EP accord-
ing to the modality that they actually received. These
groups are analogous to the “as treated” groups in a clinical
trial of two therapies. The group treated by PD contains
patients who did receive their PD choice (n = 89) and
patients who chose HD and never received it (i.e., did not
switch from PD to HD), and therefore were assigned to PD
(n = 4) by the treating clinical team for clinical reasons.
Treated by HD group contains patients who received their
HD choice (n = 70) and patients who chose PD but never
received it (i.e., did not switch from HD to PD), and
therefore were assigned to HD (n = 14) by the clinical team.
The characteristics of the groups are presented in Table 4.
The results show that compared to treated by HD patients,
treated by PD patients were significantly more comorbid
Table 3 Clinical characteristics of 177 patients who completed UPS-EP and chose a preferred dialysis modality: PD or HD
UPS patients who completed education and chose dialysis modality (n = 177) PD (n = 103) HD (n = 74) P value
Age, years 67 (38-85) 71 (36-86) 64 (4-82) 0.09
Sex, M/F, % 69 / 31 66 / 34 73 / 27 0.41
eGFR, ml/min /1.73 m2 BSA 7 [4–16] 7 [4–19] 7 [3–12] 0.34
Charlson comorbidity index, CCI 6 [2–10] 7 [2–10] 5 [3–9] 0.01
Comorbidities, %
Diabetes
Congestive heart failure
Myocardial infarct
Peripheral vascular disease
41
29
18
14
45
39
22
17
35
16
11
9
0.22
<0.01
0.07
0.19
Primary renal diseasea, %
Chronic renal failure, etiology unknown
Glomerulonephritis
Renal vascular disease
Diabetic nephropathy
Otherb
12
20
18
23
27
12
28
17
23
20
12
17
20
22
29
0.32
Patients source, %
In-patient admission
Out-patient referral
68
32
74
26
59
41
0.05
Referral, %
Primary care
Other hospital specialty
Missing/unknown
59
40
1
65
34
1
51
49
0
0.09
Hospitalization for the unplanned start, % 89 87 91 0.51
Countries, %
United Kingdom
Germany
Denmark
Sweden
Austria
France
33
40
10
6
3
8
28
48
13
7
1
3
41
27
7
5
5
15
<0.01
Values are expressed as median (10-90 percentiles) or percentage. CCI, Charlson comorbidity index; eGFR, estimated glomerular filtration rate. Significant
differences are marked in bold (p < 0.05)
aCause of renal disease
bPyelonephritis, interstitial nephropathy, cystic kidney disease, inherited renal disease, renal hypoplasia, multisystem renal disease, myeloma, amyloid, other
renal disease
Machowska et al. BMC Nephrology  (2017) 18:18 Page 7 of 12
(CCI, p = 0.04), with higher prevalence of congestive heart
failure (p < 0.01) and, were significantly more often from in-
patient admission (p = 0.02), and referred from primary care
(p = 0.02), and were differently distributed among partici-
pating countries (p < 0.001).
Clinical outcomes in UPS patients
We investigated clinical outcomes of patients who chose and
received PD (n= 89) and chose and received HD (n= 70) to
assess clinical outcomes in terms of survival and infection
rates.
Using Kaplan-Meier analysis we found no significant
difference in 1-year survival between patients who chose
and received PD and HD. We compared PD and HD with
the addition of the group of patients who chose and never
received PD (n = 14) to the HD group. There was no
significant difference in 1-year survival between the PD
and HD group. Finally, there was no significant difference
in 1-year survival between patients who were actually
treated with PD (n = 93) and HD (n = 84) respectively.
The overall peritonitis rates in PD patients were lower
than ISPD recommended targets [27]: Peritonitis rate in PD
(n = 89) patients who chose and received PD was 1 episode
per 58.1 patient months (0.21 episodes per year) and
peritonitis rate in all PD (n = 93) patients was 1 episode per
60.2 patient months (0.20 episodes per year). Similarly, the
bacteraemia rates were as follows in the HD patients:
bacteraemia rate in HD (n = 70) patients who chose and
received HD was 1 episode per 76.8 patient months (0.16
episodes per year) and bacteraemia rate in all HD (n = 84)
patients was 1 episode per 66.9 patient months (0.18
episodes per year).
Discussion
UPS patients represent a challenge in every dialysis unit
and have poor clinical outcomes – partly due to morbidity
Table 4 Clinical characteristics of 177 patients completing UPS-EP according to their actual received modality, PD (n = 85) or HD (n = 92)
Received PD (n = 93) Received HD (n = 84) P value
Age, years 70 (36-86) 65 (41-82) 0.37
Sex, M/F, % 68/32 70/30 0.75
eGFR, ml/min /1.73 m2 BSA 7 [4–18] 7 [4–15] 0.97
Charlson comorbidity index, CCI 7 [2–10] 6 [3–9] 0.04
Comorbidities, %
Diabetes
Congestive heart failure
Myocardial infarction
Peripheral vascular disease
47
40
23
16
33
18
12
11
0.07
<0.01
0.08
0.38
Primary renal diseasea, %
Chronic renal failure, etiology unknown
Glomerulonephritis
Renal vascular disease
Diabetic nephropathy
Otherb
12
29
15
25
19
12
17
21
20
30
0.18
Patients source, %
In-patient admission
Out-patient referral
76
24
58
42
0.02
Referral, %
Primary care
Other hospital specialty
Missing/unknown
68
31
1
50
50
0
0.02
Hospitalization for the unplanned start, % 88 89 1.0
Countries, %
United Kingdom
Germany
Denmark
Sweden
Austria
France
25
54
11
7
1
2
43
24
9
5
5
14
<0.001
Values are expressed as median (10-90 percentiles) or percentage.
CCI, Charlson comorbidity index; eGFR, estimated glomerular filtration rate
aCause of renal disease
bPyelonephritis, interstitial nephropathy, cystic kidney disease, inherited renal disease, renal hypoplasia, multisystem renal disease, myeloma, amyloid, other
renal disease
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and mortality associated with CVC use – compared to
planned start patients [10, 11, 29, 30]. The challenges
facing UPS patients were explored in the present study
which provided answers to several important questions;
(1)What are the characteristics of a current cohort of
UPS patients and are there issues around patient
management which are amenable to change?
(2)Is it possible to deliver an educational program to
UPS patients to allow dialysis choice?
(3)What are the outcomes if that choice is put into
practice for UPS patients?
The OPTiONS study shows that UPS patients are
similar in terms of demographics to the incident dialysis
population in the same European countries in regards to
age and gender distribution [31] with the only difference
being a higher prevalence of diabetes in the OPTiONS
study. Thus there are no fundamental case mix differ-
ences in UPS patients which should affect their ability to
receive education and make choices. However, there is
no additional information regarding other factors e.g. in-
flammatory biomarkers [32] which are associated with
comorbid illness and CKD and are associated with sur-
vival differences in patients starting dialysis. Of course,
the timing of UPS-EP needs to consider the general con-
dition and receptivity of the patient at the time of UPS.
Moreover, at dialysis start, our patients had eGFR level
comparable with other studies [33, 34] which confirms
that firstly, UPS should not be defined by a particular
eGFR level, often an element of confusion over early vs
late start. Secondly, the eGFR levels, although variable,
do not suggest that the majority of patients are progres-
sing rapidly or are presenting with minimal residual
renal function (RRF) and previously unrecognized CKD.
This is confirmed by our study since only a relatively
small percentage of patients required dialysis therapy on
the day of referral to the nephrology unit. In the major-
ity of patients there was an interval of several days –
allowing some time for preparation and education.
There is still a significant minority of UPS patients who
have been first referred many months prior to first dialy-
sis. This study cannot confirm whether or not these pa-
tients received ongoing nephrological care in a specialist
clinic but points to the observation that failures of the
care pathway in terms of patient follow up or prepar-
ation or unexpected changes in the RRF decline trajec-
tory are likely causative factors of an unplanned start in
this group of patients. Further work would be needed to
examine this in more detail and develop pathway sup-
port tools or more accurate predictive models/monitor-
ing approaches to prevent UPS.
The benefits of patient dialysis modality education are
well known [24] but it could be perceived that UPS
patients are too unwell/unstable to receive education
and make clinical decisions. However, more recent stud-
ies [3, 15, 16], albeit with a range of different UPS defini-
tions and inclusion criteria and often single centres,
have shown that education is possible and dialysis choice
can be facilitated and increase the possibility of patients
to receive home based therapy [35]. The OPTiONS
study confirms this is possible, in a range of different
renal units across different European healthcare systems,
confirming that it is achievable to a similar degree to
that reported in specific dialysis centres with particular
practice patterns [16, 19, 20]. The wide inclusion criteria
of this study was designed to allow most UPS to be in-
cluded but even so most patients were able to com-
mence (79%) and complete education (75%). This study
employed decision support tools for the first time in
UPS education, which in other long term conditions
have been shown to facilitate decision making [36] by
patients. This helped the majority of patients completing
the education to make a decision and communicate it to
their renal team. Receiving UPS-EP was a highly signifi-
cant predictor for receiving PD in the logistic regression
model. There are only small differences in patient demo-
graphics between patients who did and did not receive
UPS-EP so there should be careful clinical assessment
before making judgements over suitability for education
in UPS patients to avoid unwarranted exclusion. A small
minority still received UPS-EP up to 6 months. There-
fore design of an UPS programme should allow an ap-
proach to “capture” or “revisit” patients following their
UPS to ensure equity of access to dialysis modality choice.
The choice of modality, PD or HD, was also interesting
with perhaps counterintuitively PD choosing patients be-
ing older and more comorbid compared to those choosing
HD. In part this may reflect the practice patterns of some
of the units involved in OPTiONS with experienced PD
practitioners who may have advocate practice patterns
supportive of PD for patients with for example CHF [20].
This is a factor within the country effect noted in the
study reflecting underlying differences in practices which
play a role in modality choice. Diabetic patients were more
likely to receive PD although there is no clear evidence of
benefit of PD or HD in diabetic patients [37] and recent
ERA-EDTA data [38] show identical proportions of
diabetic patients in PD and HD in Europe. OPTiONS has
also uncovered that education and decision making are
still not enough in terms of delivering modality choice – a
small but significant number of patients expressed a pre-
ferred choice but did not receive their chosen modality.
This was particularly seen in patients who chose PD but
remained on HD. This study could not determine the
precise reasons but it does not appear to relate to patients
clinical characteristics e.g. age, comorbidity etc. Other
factors could include inability to form PD access (although
Machowska et al. BMC Nephrology  (2017) 18:18 Page 9 of 12
only seen in one patient in this study), an “overruling”
judgement from the physician, a change of the decision by
the patient, or other healthcare process issues. One
solution could be a case manager [23] to follow patients
and navigate the care pathway once a decision is made to
ensure that decisions are enacted wherever clinically
possible. Ensuring effectiveness of the access care pathway
is also important, 72 UPS patients commenced dialysis
with PD without a need of temporary HD through a
combination of medical and surgical catheter insertion
programs and PD start in a more urgent way.
Although patient centric care should support shared
decision making after patient education [39], it is important
to assess whether the choices made are “good ones” by
examining clinical outcomes. Overall patient survival was
the same in patients choosing and/or receiving PD com-
pared to those treated by HD despite the age and
comorbidity disadvantages of the PD groups. Perhaps more
importantly, in the PD patients, the peritonitis rate was well
below the recommended ISPD target and better than other
European contemporary data [40]. OPTiONS was not
powered to measure survival as a primary outcome meas-
ure and only 1 year follow up was performed, nevertheless
there are no indications that patient choice of modality as-
sociated with poor clinical outcomes in UPS patients.
Our study has several strengths. This was multicentre
study, so our findings could be applicable to other dialysis
centres elsewhere (high external validity). We aimed to
analyse a contemporary cohort of UPS patients including
as many cases of unplanned dialysis start in the centres as
possible. Moreover we have conducted the study in real
clinical settings and investigated the treatment pathways
and challenges related to UPS education, switching dialysis
modality, and hospitalization within a complex study
population. However, several limitations should be
highlighted; it was a non-interventional, observational
study, therefore a random group allocation was not
performed and confounding factors are likely to play an
important role. A randomized controlled trial of education
could in theory be performed in a cluster randomized
approach but this would be complicated by ethical con-
cerns in denying modality choice when this is known to be
important in determining clinical outcomes. Furthermore
no control group to rigorously measure the dialysis choices
and outcomes made in the same or different centres over a
different time period was included; however, it is described
consistently that renal units without a defined UPS
programme have low use of PD. The 12 months follow-up
period allowed us to only speculate on long term clinical
outcomes of patients. Since this was a “real world” study,
clinical outcomes were limited with no measurement of
parameters such as blood pressure, fluid status, dialysis
adequacy or other biochemical/haematological parameters.
Finally, we did not study the patients prior to enrolment;
thus we could not analyze the specific clinical conditions
which had prompted dialysis initiation. Overall, while the
focus of OPTiONS was on the impact of an educational
programme, its findings and strengths are in our opinion
potentially relevant for all nephrology practitioners and
could impact on everyday clinical practice.
Conclusions
The OPTiONS study of the feasibility and effective-
ness of implementing the UPS-EP, a program focusing
on patient flow and a specific educational programme
with decision support, shows that UPS (defined by re-
ferral to nephology within a month of start AND/OR
acute dialysis with CVC or PD catheter) patients who
completed UPS-EP, were more likely to choose PD as
their preferred modality. This indicates that a pro-
gramme such as the UPS-EP makes it possible to or-
ganise patient’s pathways in dialysis units to facilitate
informed choice. These findings suggest that edu-
cation facilitating informed choice of home based dia-
lysis therapies among UPS patients may lead to better
clinical outcomes and optimization of healthcare re-
source utilisation although this need to be confirmed
in further studies.
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